All-In PodcastE43: Innovative venture strategies, Zymergen's implosion, Square acquires Afterpay & more
CHAPTERS
- 0:00 – 2:05
Italy-location banter and Friedberg’s move out of San Francisco
The episode opens with the hosts roasting each other’s vacation setups (boats, beach clubs, Florence apartments) and joking about who’s actually in Italy. Friedberg shares that after 20 years he’s moved out of San Francisco, prompting more friendly ribbing.
- •Playful cold open about sunglasses, shade, and beach-club attire
- •“Guess who’s not in Italy” setup and everyone’s locations
- •Friedberg relocates out of SF (still in the Bay Area)
- •Tone-setting: informal banter before business topics
- 2:05 – 6:31
Friedberg’s Production Board raise: why go public and what they’re building
Friedberg explains The Production Board’s newly publicized funding and why they chose selective press: recruiting and awareness, not hype. He outlines the holding-company/studio approach and mentions incubated companies (including molecular beverage printing).
- •Purpose of the announcement: recruiting talent and raising awareness
- •TPB as an incubation + investment vehicle using its own balance sheet
- •Selective press strategy (single strong reporter vs broad PR push)
- •Examples of incubated/previously-stealth businesses (e.g., Canna)
- 6:31 – 8:11
Inside the TPB structure: Alphabet origins, institutional co-leads, and balance-sheet flexibility
Friedberg details TPB’s formation after discussions with Larry Page and Alphabet’s minority investment plus board seat. He describes the latest round’s institutional investors and why a capitalized holding company helps fund deep tech without forcing premature venture-mark-up incentives.
- •Alphabet’s early minority investment and governance setup
- •Latest round described as co-led by large institutions (e.g., BlackRock)
- •Why this model supports long R&D cycles without rushed fundraising
- •Flexibility to fund internally until commercialization or external capital makes sense
- 8:11 – 12:00
Venture studio model debate: focus, value creation, and ownership dynamics
Chamath and Friedberg discuss what “venture studio” means and why focus matters more than cranking out many startups. Friedberg explains how ownership varies over time, how teams are incentivized with meaningful equity, and what shared “platform value” looks like in practice.
- •Studios work best when hyper-focused in a domain (e.g., synthetic biology)
- •Goal is absolute value creation, not startup throughput
- •Equity reserved for teams; TPB can become minority owners after dilution
- •Centralized infrastructure: recruiting, finance, legal, playbooks, tooling
- 12:00 – 16:24
Sacks’ $1.12B Craft Fund III + Callin update and listener syndicate access
Sacks breaks down Craft’s new fund split between venture and growth, and reiterates focus on SaaS and marketplaces. The group then pivots to Callin’s product thesis—podcasting meets social audio—and the All-In Syndicate’s no-fee/no-carry listener allocation.
- •Fund size and split: venture vs growth strategy
- •SaaS thesis: consumer-style growth tactics applied to enterprise (bottom-up adoption)
- •Marketplace focus and why these models scale well
- •Callin’s differentiation vs Clubhouse: RSS syndication + better persistence
- •All-In Syndicate mechanics: small listener allocation, lottery, no carry/fees
- 16:24 – 30:41
Innovative venture strategies: internal markups, doubling down, and governance risks
Jason tees up a critique of firms “marking up their own book” by investing across multiple internal rounds at higher valuations. Chamath and Friedberg frame why big brands do it (AUM velocity, LP preferences) but warn the real issue becomes governance—especially when too much money meets too little oversight.
- •Internal follow-on rounds can manufacture valuation momentum
- •Chamath’s take: venture is scaling like PE; big brands optimize velocity of money
- •LP reality: large checks, low hurdle rates, predictable fundraising cadence
- •Counterpoint: strategy can work for high-conviction winners (Sequoia-style)
- •Core risk: weak governance when boards lack investor diversity
- 30:41 – 37:05
Zymergen implodes: what synthetic biology platforms promise vs product-market reality
The group dissects Zymergen’s dramatic post-IPO collapse after admitting its product pipeline and revenue expectations won’t materialize soon. Friedberg explains the synthetic biology “platform” pitch, how Zymergen evolved from services to products, and why deep tech unit economics and timelines routinely break hype-driven projections.
- •Zymergen’s disclosure: no meaningful product revenue in 2021/2022 and CEO exit
- •What “synthetic biology platform” companies claim to do (cells making materials/food/enzymes)
- •Early model: paid R&D/services with big partners and hoped-for royalties
- •Pivot to in-house product strategy and why it remained hard to commercialize
- •Deep tech trap: big valuations + big burn before true PMF emerges
- 37:05 – 56:43
Diligence, milestones, and why deep tech invites narrative-driven investing (and fraud)
The hosts contrast milestone-based financing in SaaS/marketplaces with deep tech pitches built on proxy metrics and assumptions. They debate how IPOs and late-stage funding can amplify these failures, and why “belief over logic” becomes contagious during frothy markets.
- •Sacks’ view: Craft invests with revenue/proof milestones; SoftBank-style checks are antithetical
- •Deep tech often substitutes proxy metrics (experiments/day → discoveries → revenue) for traction
- •Market dynamics: FOMO + narrative can override basic verification
- •Chamath’s critique: some investors fund what they don’t understand, leading to fragile outcomes
- •Key distinction: funding narratives is fine early; dangerous at $100M+ check sizes
- 56:43 – 59:19
Employees get burned: option exercise, taxes, and the hidden cost of hype collapses
Friedberg highlights a less-discussed consequence of Zymergen’s crash: employees exercising options near IPO and facing tax obligations based on higher valuations, only to see share prices crater. The group argues the damage extends beyond investors to workers who trusted perceived validation from major backers and underwriters.
- •How option exercise and tax treatment can trap employees when stock drops post-IPO
- •IPO pricing can create “paper gains” tax bills before liquidity
- •“Signaling” from big investors encourages talent to join, sometimes falsely
- •Why governance and accountability matter for public-market transitions
- 59:19 – 1:04:17
Theranos war stories: red flags, board credibility theater, and ‘show me the device’
Chamath recounts early skepticism about Theranos’ board composition and a senior candidate’s bizarre interview process (kept outside reception, no device demo). Jason adds his CNBC comments and an awkward run-in with Elizabeth Holmes, emphasizing a simple heuristic: if the product is real, you show it.
- •Board as a red flag: credibility theater vs domain expertise
- •Interview secrecy as signal: no lab access, no device demo, fast offer pressure
- •Jason’s heuristic: real tech gets demonstrated; fraud hides behind secrecy
- •Theranos as a cautionary tale for narrative-first capital allocation
- 1:04:17 – 1:07:38
Calling out frauds and the next target: Tether and stablecoin transparency
Jason argues that a wave of high-profile startup deception (Theranos, Nikola, Zymergen) should make investors more aggressive about verification. He then singles out Tether (USDT), outlining concerns about reserves, offshore exchange opacity, and why he believes it could be a systemic weak point in crypto markets.
- •Why “never bend or exaggerate” in fundraising (securities fraud risk)
- •Nikola indictment referenced as an example of consequences for deception
- •Tether skepticism: reserve backing, regulatory actions, and opacity
- •Stress-testing and custody issues on offshore exchanges
- 1:07:38 – 1:11:06
Financial deplatforming: PayPal’s ‘no-buy list’ and the politics of access
Sacks pivots to what he sees as a major civic risk: payment platforms denying service based on controversial third-party lists. He argues financial access is more consequential than speech-platform access and calls for political oversight, warning this could become the next major censorship battleground.
- •PayPal partnering with advocacy groups to operationalize account bans
- •Concern over mission creep and errors/overreach in blacklist-style systems
- •Claim: losing financial access threatens livelihoods more than losing social-media reach
- •Prediction: financial deplatforming becomes a major political issue
- 1:11:06 – 1:25:07
Square acquires Afterpay: ‘feature vs company’ and the future of fintech superpowers
The hosts analyze Square’s $30B Afterpay deal, including the dilution optics and the strategic two-sided marketplace rationale. Chamath argues “buy now, pay later” is ultimately a feature, and that public markets reward platforms that assemble adjacent capabilities—especially when regulatory licensing lowers cost of capital and enables consolidation across fintech categories.
- •Deal structure and dilution vs revenue contribution critique
- •Buy-now-pay-later mechanics and merchant conversion benefits
- •Chamath: market rewarded Square; platforms can acquire features ‘for free’ if strategy is coherent
- •Friedberg’s fintech stack thesis: banking, lending, trading, crypto, insurance converging into a few superpowers
- •Regulatory gate: federal banking licenses shape who can consolidate at scale
- 1:25:07 – 1:31:10
Wrap: Italy logistics, bestie plans, Robinhood congrats, and the episode sign-off
The show closes by circling back to travel bragging and attempts to convince Friedberg to fly to Italy. They congratulate Jason on Robinhood-related wins, joke about Sacks’ mysterious ‘billion-dollar week,’ and end with more banter.
- •Back-and-forth about meeting up in Italy and travel logistics
- •Jokes about wealth, yachts, and ‘who’s not in Italy’
- •Robinhood congrats and fund performance chatter
- •Teaser about Sacks’ unspecified big financial week; sign-off
